CON vs FMS vs DVA Stock Comparison

Concentra Group Holdings Parent, Fresenius Medical Care AG and Davita Prices as of Oct 23, 2026 Peers: Industry group
FMS Fresenius Medical Care AG
$22.68 +1.2% 1M -15.8% 1Y
Market cap
$13.25B
P/E
12.1x
Revenue (TTM)
$11.07B
Div. yield
–
Healthcare Services Healthcare
4 wins
DVA Davita Inc.
$183.65 +0.3% 1M +43.5% 1Y
Market cap
$11.89B
P/E
14.0x
Revenue (TTM)
$14.01B
Div. yield
–
Healthcare Services Healthcare
3 wins

Head to Head

11 decided of 12

Fresenius Medical Care AG leads on 4 of the 12 questions below (Fresenius Medical Care AG 4, Concentra Group Holdings Parent 4, Davita 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCONFMSDVALeader
Larger companyMarket capitalisation $5.03B $13.25B $11.89B FMS
Cheaper on earningsLower P/E, profitable companies only 25.3x 12.1x 14.0x FMS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.8x 9.5x 12.0x FMS
Faster revenue growthRevenue growth, trailing twelve months +14.0% -47.8% +6.4% CON
More profitableNet margin, trailing twelve months 8.7% 9.9% 6.0% FMS
Better return on capitalReturn on invested capital 14.2% 0.2% 17.0% DVA
Less leveragedLower net debt / EBITDA 3.1x 200.7x 3.6x CON
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +91.2% -15.8% +43.5% CON
Better 5-year returnAnnualised price return, 5 years — -8.6%/yr +9.7%/yr DVA
Less volatileAnnualised volatility, 1 year 27.8% 31.1% 45.2% CON
Higher overall scoreMean of the five percentile scores vs peers 57/100 50/100 67/100 DVA

Percentile Scorecard

CONFMSDVA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCONFMSDVA
Valuation 59 #39 of 93 73 #26 of 93 95 #6 of 93
Growth 64 #32 of 88 12 #78 of 88 35 #58 of 88
Profitability 86 #13 of 87 62 #34 of 87 84 #15 of 87
Financial Health 27 #73 of 100 13 #87 of 100 28 #72 of 100
Shareholder Returns 51 #28 of 56 91 #6 of 56 95 #4 of 56
Overall 57 50 67
  • CON ranked among 103 companies in Healthcare Providers
  • FMS ranked among 103 companies in Healthcare Providers
  • DVA ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCONFMSDVASPY
1 month +12.9%+1.2%+0.3% -1.0%
3 months +24.3%-7.8%-22.0% +2.9%
6 months +72.2%-0.4%+20.9% +6.4%
Year to date +99.6%-4.8%+61.6% +11.4%
1 year +91.2%-15.8%+43.5% +13.1%
3 years —+30.7%+126.4% +79.4%
3 years, per year —+9.3%+31.3% +21.5%
5 years —-36.3%+58.9% +67.7%
5 years, per year —-8.6%+9.7% +10.9%
10 years —-45.3%+201.3% +255.2%
10 years, per year —-5.9%+11.7% +13.5%

Risk

MeasureCONFMSDVASPY
Volatility, 1Y 27.8%31.1%45.2% 12.7%
Downside volatility, 1Y 23.1%36.8%41.1% 12.7%
Beta vs S&P 500, 1Y 0.410.20-0.03 1.00
Return / volatility, 1Y 3.28-0.510.96 1.03
Max drawdown, 5Y -23.5%-64.2%-47.0% -25.4%
From 52-week high -1.7%-16.7%-23.8% -2.5%
52-week high $39.97$27.24$240.98 $779.14
52-week low $18.71$20.19$103.87 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCONFMSDVA
P/E now vs peer median 24.7xmedian 25.3x 12.1xmedian 25.3x 14.0xmedian 25.3x
P/S now vs peer median 2.2xmedian 1.6x 1.1xmedian 1.6x 0.8xmedian 1.6x
EV/EBITDA now vs peer median 14.0xmedian 14.6x 205.4xmedian 14.6x 7.7xmedian 14.6x
P/FCF now vs peer median 18.7xmedian 22.7x 6.1xmedian 22.7x 7.3xmedian 22.7x
P/B now vs peer median 10.3xmedian 3.3x 0.8xmedian 3.3x -15.4xmedian 3.3x
PEG now vs peer median —median 0.66 0.58median 0.66 0.38median 0.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCONFMSDVA
Revenue $2.29B $11.07B $14.01B
Gross profit $670.56M -$5.62B $4.53B
Operating income $374.81M $879.32M $2.13B
Net income $203.80M $1.38B $1.19B
Free cash flow $267.42M $2.08B $1.61B
R&D – $180.01M –
EPS (diluted) $1.56 $1.79 $12.82
Cash & equivalents $158.04M $1.21B $668.96M
Total debt $1.57B $572.99B $41.93B
Shares (diluted) 127.79M 612.52M 66.09M
Enterprise value $4.68B $5.20B $9.10B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCONFMSDVA
P/E 24.7x 12.1x 14.0x
P/FCF 18.7x 6.1x 7.3x
P/Operating cash flow 14.9x 3.8x 5.4x
P/S 2.2x 1.1x 0.8x
P/B 10.3x 0.8x -15.4x
P/Tangible book 19.8x 0.9x -11.8x
EV/EBITDA 14.0x 205.4x 7.7x
EV/EBIT 17.1x 628.3x 10.3x
EV/Revenue 2.8x 49.9x 1.6x
EV/FCF 24.0x 265.7x 13.6x
EV/Operating cash flow 19.2x 167.5x 10.0x
PEG (3Y EPS CAGR) – 0.58 0.38

Growth

14 metrics
MetricCONFMSDVA
Revenue growth (1Y) 14.0% -47.8% 6.4%
Revenue CAGR (3Y) – -18.6% 6.1%
Gross profit growth (1Y) 18.9% -207.2% 5.8%
Gross profit CAGR (3Y) – -45.2% 9.5%
Operating income growth (1Y) 18.9% -45.5% 2.4%
Operating income CAGR (3Y) – -16.4% 18.3%
Net income growth (1Y) 32.6% 49.8% 3.2%
Net income CAGR (3Y) – 18.2% 18.9%
EPS growth (1Y) 33.5% 52.0% 18.6%
EPS CAGR (3Y) – 20.9% 36.8%
Operating cash flow growth (1Y) 29.2% 9.3% 17.8%
Operating cash flow CAGR (3Y) – 9.3% 3.7%
Free cash flow growth (1Y) 43.1% -7.7% 25.0%
Free cash flow CAGR (3Y) – 4.8% 5.9%

Profitability

14 metrics
MetricCONFMSDVA
Gross margin 29.3% -50.7% 32.4%
EBITDA margin 20.0% 24.3% 20.3%
Operating margin 16.4% 7.9% 15.2%
Pretax margin 11.7% 15.8% 10.5%
Net margin 8.7% 9.9% 6.0%
FCF margin 11.7% 18.8% 11.5%
Operating cash flow margin 14.7% 29.8% 15.7%
Return on equity 44.8% 2.7% –
Return on assets 7.0% 1.2% 6.8%
Return on invested capital 14.2% 0.2% 17.0%
Return on capital employed 14.5% 3.2% 14.4%
Asset turnover 0.8x 0.3x 0.8x
Cash conversion (OCF / net income) 1.6x 2.4x 1.8x
Stock comp / revenue 0.6% – 0.9%

Financial Health

11 metrics
MetricCONFMSDVA
Debt / assets 52.3% 1,515% 60.9%
Debt / equity 3.2x 35.0x -14.1x
Net debt / EBITDA 3.1x 200.7x 3.6x
Debt / FCF 5.9x 260.4x 6.7x
Liabilities / assets 83.9% 56.8% 104.3%
Equity / assets 16.1% 43.2% -4.3%
Interest coverage – 2.0x 3.6x
Current ratio 1.4x 1.1x 1.5x
Quick ratio 1.2x 0.2x 1.3x
Cash ratio 0.4x 0.2x 0.2x
Altman Z-score 2.53 1.33 1.67

Shareholder Returns

7 metrics
MetricCONFMSDVA
Dividend yield 0.6% 3.8% –
Net buyback yield 0.5% 8.5% 13.1%
Shareholder yield 1.1% 12.3% 13.1%
Payout ratio (earnings) 15.7% – –
Payout ratio (FCF) 12.0% – –
Dividend growth (1Y) 33.4% – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCONFMSDVA
Forward P/E 22.8xFY2026 9.5xFY2026 12.0xFY2026
EPS, next fiscal year $1.72FY2026 $2.39FY2026 $15.33FY2026
EPS growth, next FY +25.5%FY2026 -5.2%FY2026 +42.2%FY2026
EPS growth, the year after +10.5% +6.7% +13.6%
Revenue, next fiscal year $2.30BFY2026 $21.59BFY2026 $14.43BFY2026
Revenue growth, next FY +6.3%FY2026 -6.6%FY2026 +5.8%FY2026
Revenue growth, the year after +2.7% -0.3% -3.3%
CON estimates →FMS estimates →DVA estimates →

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCONFMSDVA
Held by institutions 87.3% 7.3% 91.0%
Institutions holding 291 235 622
Change in shares held, QoQ +4.0% -2.9% -5.0%
Institutions buying 166 151 303
Institutions selling 81 41 223
Buyers to sellers 2.05 3.68 1.36
CON holders →FMS holders →DVA holders →

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CONFMSDVA
CON 1.00 0.27 0.30
FMS 0.27 1.00 0.32
DVA 0.30 0.32 1.00

Add a Peer

Largest companies in the same industry
CON · Healthcare Services
+RDNTRadNet +LFSTLifeStance Health +SGRYSurgery Partners +PRVAPrivia Health +MDPediatrix Medical +PGNYProgyny +USPHU S Physical Therapy +STLNStarling Oncology
Plot all 84 Healthcare Services stocks →

Related Comparisons

CON vs RDNTRadNet CON vs LFSTLifeStance Health CON vs SGRYSurgery Partners CON vs PRVAPrivia Health

Frequently Asked Questions

Which is bigger, CON, FMS and DVA?

Fresenius Medical Care AG (FMS) is the largest by market capitalisation: Concentra Group Holdings Parent (CON) $5.03B, Fresenius Medical Care AG (FMS) $13.25B, Davita (DVA) $11.89B.

Which stock is cheaper, CON, FMS and DVA?

Fresenius Medical Care AG (FMS) trades on the lowest price-to-earnings ratio (Concentra Group Holdings Parent (CON) 25.3x, Fresenius Medical Care AG (FMS) 12.1x, Davita (DVA) 14.0x). On next year's consensus earnings, Fresenius Medical Care AG (FMS) is cheapest (Concentra Group Holdings Parent (CON) 22.8x, Fresenius Medical Care AG (FMS) 9.5x, Davita (DVA) 12.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Concentra Group Holdings Parent (CON) grew revenue fastest over the trailing twelve months: Concentra Group Holdings Parent (CON) +14.0%, Fresenius Medical Care AG (FMS) -47.8%, Davita (DVA) +6.4%.

Which company is more profitable?

Fresenius Medical Care AG (FMS) has the highest net margin (Concentra Group Holdings Parent (CON) 8.7%, Fresenius Medical Care AG (FMS) 9.9%, Davita (DVA) 6.0%). On return on invested capital, Davita (DVA) leads (Concentra Group Holdings Parent (CON) 14.2%, Fresenius Medical Care AG (FMS) 0.2%, Davita (DVA) 17.0%).

Which stock has performed better?

Over the past year Concentra Group Holdings Parent (CON) returned the most: Concentra Group Holdings Parent (CON) +91.2%, Fresenius Medical Care AG (FMS) -15.8%, Davita (DVA) +43.5%. Over five years, Davita (DVA) compounded fastest (Fresenius Medical Care AG (FMS) -8.6%/yr, Davita (DVA) +9.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Concentra Group Holdings Parent (CON) 0.01%, Fresenius Medical Care AG (FMS) 0.00%, Davita (DVA) 0.00%. Fresenius Medical Care AG (FMS) and Davita (DVA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Concentra Group Holdings Parent (CON) has been the steadiest (Concentra Group Holdings Parent (CON) 27.8%, Fresenius Medical Care AG (FMS) 31.1%, Davita (DVA) 45.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CON, FMS and DVA?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Fresenius Medical Care AG (FMS) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.